Search

Your search keyword '"Abufaraj, Mohammad"' showing total 840 results

Search Constraints

Start Over You searched for: Author "Abufaraj, Mohammad" Remove constraint Author: "Abufaraj, Mohammad"
840 results on '"Abufaraj, Mohammad"'

Search Results

2. Preoperative Plasma Insulin-Like Growth Factor-I and Its Binding Proteins-Based Risk Stratification of Patients Treated With Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma

4. Comparison between different neoadjuvant chemotherapy regimens and local therapy alone for bladder cancer: a systematic review and network meta-analysis of oncologic outcomes

5. Impact of sex on outcomes after surgery for non-muscle-invasive and muscle-invasive bladder urothelial carcinoma: a systematic review and meta-analysis

6. Carboplatin Induction Chemotherapy in Clinically Lymph Node–positive Bladder Cancer

7. Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancer

8. Follow-up of the Urethra and Management of Urethral Recurrence After Radical Cystectomy: A Systematic Review and Proposal of Management Algorithm by the European Association of Urology—Young Academic Urologists: Urothelial Carcinoma Working Group

9. Reassessment of the Efficacy of Carboplatin for Metastatic Urothelial Carcinoma in the Era of Immunotherapy: A Systematic Review and Meta-analysis

10. Prognostic Role of Preoperative Vascular Cell Adhesion Molecule-1 Plasma Levels in Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy

11. The Role of Prior Bladder Cancer on Recurrence in Patients Treated with Radical Nephroureterectomy

12. Neoadjuvant Chemotherapy in Elderly Patients With Upper Tract Urothelial Cancer: Oncologic Outcomes From a Multicenter Study

13. Comparative Outcomes of Primary Versus Recurrent High-risk Non–muscle-invasive and Primary Versus Secondary Muscle-invasive Bladder Cancer After Radical Cystectomy: Results from a Retrospective Multicenter Study

14. Accuracy of Frozen Section Analysis of Urethral and Ureteral Margins During Radical Cystectomy for Bladder Cancer: A Systematic Review and Diagnostic Meta-Analysis

15. Accuracy and Clinical Utility of a Tumor Grade- and Stage-based Predictive Model in Localized Upper Tract Urothelial Carcinoma

16. Current application of the enhanced recovery after surgery protocol for patients undergoing radical cystectomy: lessons learned from European excellence centers

18. Novel Classification for Upper Tract Urothelial Carcinoma to Better Risk-stratify Patients Eligible for Kidney-sparing Strategies: An International Collaborative Study

19. Intravesical Therapy in Patients with Intermediate-risk Non–muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis of Disease Recurrence

21. Impact of preoperative plasma levels of interleukin 6 and interleukin 6 soluble receptor on disease outcomes after radical cystectomy for bladder cancer

22. Incidence, risk factors and outcomes of urethral recurrence after radical cystectomy for bladder cancer: A systematic review and meta-analysis

24. Pretreatment Risk Stratification for Endoscopic Kidney-sparing Surgery in Upper Tract Urothelial Carcinoma: An International Collaborative Study

29. Prognostic value of the pre-operative serum albumin to globulin ratio in patients with non-metastatic prostate cancer undergoing radical prostatectomy

31. Prognostic role of the systemic immune–inflammation index in upper tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration

32. Surveillance of non‐muscle‐invasive bladder cancer with blue‐light cystoscopy: a meta‐analysis.

33. Adjuvant intravesical therapy in intermediate‐risk non‐muscle‐invasive bladder cancer.

39. Preoperative plasma insulin-like growth factor-I and its binding proteins-based risk stratification of patients treated with radical nephroureterectomy for upper tract urothelial carcinoma

40. MP51-04 PROGNOSTIC VALUE OF INSULIN-LIKE GROWTH FACTOR-I AND ITS BINDING PROTEINS-BASED IN PATIENTS TREATED WITH RADICAL NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA

41. MP38-07 INTERLEUKIN-6 AND ITS SOLUBLE RECEPTOR AS BLOOD-BASED BIOMARKERS PREDICTING DISEASE OUTCOMES AFTER RADICAL NEPHROURETERECTOMY IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA

42. MP38-06 PROGNOSTIC SIGNIFICANCE OF VCAM AND VEGF LEVELS PRIOR TO RADICAL NEPHROURETERECTOMY ON TREATMENT OUTCOMES

43. MP08-11 IMPACT OF PRE-SURGERY EGFR AND HER2 PLASMA LEVELS ON POST-SURGICAL OUTCOMES IN BLADDER CANCER PATIENTS RECEIVING RADICAL CYSTECTOMY

45. Adjuvant chemotherapy is ineffective in patients with bladder cancer and variant histology treated with radical cystectomy with curative intent

Catalog

Books, media, physical & digital resources